Scaffold-based novel SHP2 allosteric inhibitors design using Receptor-Ligand pharmacophore model, virtual screening and molecular dynamics. - Wen-Yan Jin; Ying Ma; Wei-Ya Li; Hong-Lian Li; Run-Ling Wang (Comput. Biol. Chem., 2018)

Exploring the reason for increased activity of SHP2 caused by D61Y mutation through molecular dynamics. - Rui-Rui Wang; Ying Ma; Shan Du; Wei-Ya Li; Ying-Zhan Sun; Hui Zhou; Run-Ling Wang (Comput. Biol. Chem., 2019)

Structure based design of selective SHP2 inhibitors by De novo design, synthesis and biological evaluation. - Wen-Shan Liu; Wen-Yan Jin; Liang Zhou; Xing-Hua Lu; Wei-Ya Li; Ying Ma; Run-Ling Wang (J. Comput. Aided Mol. Des., 2019)